These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12322805)

  • 1. Acetazolamide-induced muscle weakness in hypokalemic periodic paralysis.
    Ikeda K; Iwasaki Y; Kinoshita M; Yabuki D; Igarashi O; Ichikawa Y; Satoyoshi E
    Intern Med; 2002 Sep; 41(9):743-5. PubMed ID: 12322805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokalemic periodic paralysis exacerbated by acetazolamide.
    Torres CF; Griggs RC; Moxley RT; Bender AN
    Neurology; 1981 Nov; 31(11):1423-8. PubMed ID: 7031501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between hyperinsulinemia and hypokalemic periodic paralysis in overweight/obesity subjects].
    Chen DM; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):592-5. PubMed ID: 24059115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal Muscle Weakness With Overlying Hypokalemic Periodic Paralysis in Sjögren Syndrome: Report of 6 Cases.
    Paliwal VK; Rai AS; Kumar S; Verma R; Agarwal V
    J Clin Rheumatol; 2020 Jan; 26(1):24-27. PubMed ID: 29667944
    [No Abstract]   [Full Text] [Related]  

  • 5. The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.
    Ke Q; He F; Lu L; Yu P; Jiang Y; Weng C; Huang H; Yi X; Qi M
    Neuromuscul Disord; 2015 Dec; 25(12):955-8. PubMed ID: 26433613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Aetiological Spectrum of Hypokalemic Flaccid Paralysis in Western Odisha.
    Mohapatra BN; Lenka SK; Acharya M; Majhi C; Oram G; Tudu KM
    J Assoc Physicians India; 2016 May; 64(5):52-58. PubMed ID: 27735149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect upon serum insulin, glucose and potassium concentrations of acetazolamide during attacks of familial periodic hypokalemic paralysis.
    Johnsen T
    Acta Neurol Scand; 1977 Dec; 56(6):533-41. PubMed ID: 605775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypokalemic periodic paralysis with topiramate.
    Fiore DM; Strober JB
    Muscle Nerve; 2011 Jan; 43(1):127-9. PubMed ID: 21171065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis.
    Tricarico D; Barbieri M; Camerino DC
    Ann Neurol; 2000 Sep; 48(3):304-12. PubMed ID: 10976636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
    Vicart S; Sternberg D; Fournier E; Ochsner F; Laforet P; Kuntzer T; Eymard B; Hainque B; Fontaine B
    Neurology; 2004 Dec; 63(11):2120-7. PubMed ID: 15596759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. A possible relationship to acetazolamide's beneficial effect in hypokalemic periodic paralysis.
    Riggs JE; Griggs RC; Moxley RT
    Arch Neurol; 1984 Jan; 41(1):35-8. PubMed ID: 6689885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary hypokalemic paralysis with bulbar weakness and reversible electrophysiologic abnormalities: A case report and systematic review.
    Ignacio KHD; Bagnas MAC; Espiritu AI; Reyes JPBT
    J Clin Neurosci; 2019 Dec; 70():254-257. PubMed ID: 31439490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency.
    Lanzi R; Previtali SC; Sansone V; Scavini M; Fortunato M; Gatti E; Meola G; Bosi E; Losa M
    J Endocrinol Invest; 2007 Apr; 30(4):341-5. PubMed ID: 17556873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Recurrent hypokalemic periodic paralysis associated with distal renal tubular acidosis (type 1) and hypothyroidism secondary to Hashimoto's thyroiditis.
    Meregildo-Rodríguez ED; Failoc-Rojas VE
    F1000Res; 2018; 7():1154. PubMed ID: 30647907
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment for periodic paralysis.
    Sansone V; Meola G; Links TP; Panzeri M; Rose MR
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005045. PubMed ID: 18254068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-enteritis in hypokalemic periodic paralysis: a life threatening condition.
    Ebus S; Verrips A; Ginjaar IB; Verhagen WI
    Clin Neurol Neurosurg; 2012 Jul; 114(6):801-2. PubMed ID: 22311001
    [No Abstract]   [Full Text] [Related]  

  • 17. Etiologic and therapeutic analysis in patients with hypokalemic nonperiodic paralysis.
    Sung CC; Cheng CJ; Chiang WF; Chau T; Hsu YJ; Yang SS; Lin SH
    Am J Med; 2015 Mar; 128(3):289-96.e1. PubMed ID: 25447623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent muscle weakness in hypokalemic periodic paralysis.
    Holm-Yildiz S; Witting N; Dahlqvist J; de Stricker Borch J; Solheim T; Fornander F; Eisum AS; Duno M; Soerensen T; Vissing J
    Neurology; 2020 Jul; 95(4):e342-e352. PubMed ID: 32580975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unexpected cause of proximal myopathy.
    Townsend SA; Smith M; Harris W; Chudleigh R
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22751421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide-induced weakness in paramyotonia congenita.
    Riggs JE; Griggs RC; Moxley RT
    Ann Intern Med; 1977 Feb; 86(2):169-73. PubMed ID: 835937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.